Lisdexamfetamine Dimesylate

Spezifikationen

608137-33-3CAS-Nummer

(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acidIUPAC-Name

C17H33N3O7S2Chemische Formel

455.6 g/molMolekulargewicht

Lisdexamfetamine dimesylate; Vyvanse; 608137-33-3; Lisdexamfetamine mesilate; NRP-104; SPD489; Tyvense; lis-dexamfetamine dimesylate; NRP104; SJT761GEGS; NRP 104; SPD-489; Lisdexamfetamine dimesilate; Lisdexamphetamine dimesilate; Lisdexamfetamine dimethanesulfonate; DTXSID60209653; Dimesylate, Lis-dexamfetamine; elvanse; Elvanse adult; RefChem:57033; Dimesylate, Lisdexamfetamine; Lis dexamfetamine Dimesylate; DTXCID10132144; Lisdexamfetamine dimesylate capsules; Lisdexamfetamine mesylate; UNII-SJT761GEGS; Lisdexamfetamine dimesylate [USAN]; L-Lysine-d-amphetamine dimesylate; Lisdexamphetamine Dimesylate; Lisdexamfetamine mesilate (JAN); Lisdexamfetamine dimesylate (USAN); (2S)-2,6-DIAMINO-N-[(1S)-1-METHYL-2-PHENYLETHYL]HEXANAMIDE DIMETHANESULFONATE; LISDEXAMFETAMINE MESILATE [JAN]; Venvanse; Lys-Amp; SPD 489; Lys-d-Amp; Elvanse (TN); Vyvanse (TN); ARYNTA; SCHEMBL678421; CHEMBL1201178; C17H33N3O7S2; AKOS030254940; (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid; LISDEXAMFETAMINE MESILATE [MART.]; FL162437; LISDEXAMFETAMINE MESILATE [WHO-DD]; LISDEXAMFETAMINE DIMESYLATE [VANDF]; NS00076353; D04747; LISDEXAMFETAMINE DIMETHANESULFONATE [MI]; LISDEXAMFETAMINE DIMESYLATE [ORANGE BOOK]; Q27289243; (S)-2,6-Diamino-N-((S)-1-phenylpropan-2-yl)hexanamide dimethanesulfonate; Methanesulfonic acid--N-[(2S)-1-phenylpropan-2-yl]-L-lysinamide (2/1); (2S)-2,6-DIAMINO-N-((1S)-1-METHYL-2-PHENYLETHYL)HEXANAMIDE DIMETHANESULPHONATE; (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenyl-ethyl]hexanamide;methanesulfonic acid; HEXANAMIDE, 2,6-DIAMINO-N-((1S)-1-METHYL-2-PHENYLETHYL), (2S), DIMETHANESULFONATE; HEXANAMIDE, 2,6-DIAMINO-N-((1S)-1-METHYL-2-PHENYLETHYL), (2S), DIMETHANESULPHONATESynonyme